Abstract:This study analysed the relationship between serum progesterone/oestradiol concentrations and IVF pregnancy outcomes in gonadotrophin-releasing hormone agonist protocols. A total of 2921 infertile women undergoing IVF were assigned to four groups according to serum progesterone and oestradiol concentrations on the day of human chorionic gonadotrophin (HCG) administration: group 1 (control) progesterone<3.34 nmol/l and oestradiol<19,124 pmol/l; group 2 (high oestradiol); group 3 (high progesterone); group 4 (high progesterone and high oestradiol). Compared with group 1, group 4 had lower clinical pregnancy and live birth rates as well as the highest ectopic pregnancy rate (29.15% versus 45.91%; 18.67% versus 34.34%; 18.10% versus 5.82%; P<0.05). Group 3 had lower clinical pregnancy and live birth rates per embryo-transfer cycle (29.78% versus 45.91%; 20.28% versus 34.34%, respectively; P<0.05). Clinical pregnancy rates were similar in frozen-thawed embryo transfers (FET) among the four groups. In conclusion, elevated progesterone was detrimental to live birth rates. High serum oestradiol concentration on HCG day did not affect the IVF pregnancy outcome. In combination with the elevated progesterone, high oestradiol concentrations had a potential negative effect. For these patients, FET should be suggested to improve the pregnancy outcomes. The aim of this study was to analyse the relationship between serum progesterone/oestradiol concentrations and IVF pregnancy outcomes in gonadotrophin-releasing hormone agonist protocols. A total of 2921 infertile women undergoing IVF were assigned to four groups according to their serum progesterone and oestradiol concentrations on the day of human chorionic gonadotrophin (HCG) administration: group 1 (control) progesterone<3.34 nmol/l and oestradiol<19,124 pmol/l; group 2 (high oestradiol); group 3 (high progesterone); group 4 (high progesterone and high oestradiol). Compared with group 1, patients in group 4 had lower clinical pregnancy (29.15% versus 45.91%) and live birth rates (18.67% versus 34.34%) as well as the highest ectopic pregnancy rate (18.1% versus 5.82%) (all P<0.05). Those in group 3 had lower clinical pregnancy and live birth rates per embryo transfer cycle (29.78% versus 45.91%; 20.28% versus 34.34%, respectively, P<0.05). Embryo quality appeared to be unaffected since similar clinical pregnancy rates in frozen-thawed embryo transfer (FET) cycles among the four groups. In conclusion, elevated progesterone was detrimental to live birth rates. A high serum oestradiol concentration on the day of HCG administration did not affect the IVF pregnancy outcome. In combination with the elevated progesterone and oestradiol concentrations had a potential negative effect. For these patients, FET should be suggested to improve the pregnancy outcomes.

Significance of Serum Estradiol Monitoring in Hormone Replacement-Frozen Embryo Transfer Cycles

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium.

Comparison of Progesterone Measurement on Day Of, and Day After, HCG Administration in IVF–embryo Transfer Cycles

[Application of Femoston in hormone replacement treatment-frozen embryo transfer and its clinical outcomes].

A Clinical Study on the Level of Serum Low Progesterone about Luteal Phase Support for Partial Vaginal Delivery in Assisted Reproductive Technology

Effects of serum estrogen levels before frozen-thawed blastocyst transfer on pregnancy outcomes in hormone replacement cycles

The influence of progesterone and estradiol level on the day on clinical outcome of frozen thawed embryo transfer in nature cycle.

The Relationship Between Serum Oestrogen Levels and Clinical Outcomes of Hormone Replacement Therapy-Frozen Embryo Transfer: a Retrospective Clinical Study.

The effect of different estradiol concentrations on the day of HCG administration on pregnancy outcome of fresh IVF cycles and subsequent frozen-thawed embryo transfer cycles

Estrogen Level Monitoring in Artificial Frozen-Thawed Embryo Transfer Cycles Using Step-Up Regime Without Pituitary Suppression: is It Necessary?

THE RELATIONSHIP BETWEEN SERUM ESTROGEN (E2) LEVELS AND OUTCOMES OF HORMONE REPLACEMENT THERAPY-FROZEN EMBRYO TRANSFER (HRT-FET).

Serum Progesterone Concentration on Day of HCG Administration and IVF Outcome

Association Between Serum Estradiol Level on the Human Chorionic Gonadotrophin Administration Day and Clinical Outcome.

Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles

Influence of serum estradiol mass concentrations on day of hCG administration during in vitro fertilization on pregnancy outcomes

Serum Estradiol Level and Progesterone/Estradiol Ratio Per Follicle on HCG Administration Day in Relation to Outcomes of in Vitro Fertilization and Embryo Transfer

Effect of serum progesterone variation in late follicular phase on clincal outcome in women undergoing IVF-ET with standard long protocols

The effect of peak serum estradiol level during ovarian stimulation on cumulative live birth and obstetric outcomes in freeze-all cycles

Serum Progesterone Levels on the Day of Oocyte Retrieval and the Quantity of Viable Embryos/Pregnancy Outcomes during ICSI Cycles

Evaluation of the predictive value for IVF outcomes of serum estrogen level after down regulation